ArticleFrontiers in surgery2025
Clinical decision system for renal cell carcinoma integrating interpretable machine learning algorithms.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kidney cancer is a highly heterogeneous oncologic disease with historically poor prognosis. Precise assessment of the risk of distal metastasis can facilitate risk stratification and improve prognosis for kidney cancer patients. Methods: Data from the Surveillance, Epidemiology, and End Results (SEER) database, we identified 40,527 kidney cancer patients diagnosed between 2010 and 2017 were obtained. LASSO, univariate and multivariate logistic regression analyses were employed to screen independent risk factors for distal metastasis. Six machine learning (ML) algorithms including logistic regression (LR), Naïve Bayes Classifier (NBC), Decision Tree (DT), Random Forest (RF), Gradient boosting machine (GBM) and Extreme gradient boosting (XGB), were further applied to build the predictive models. After testing with ten-fold cross-validation and receiver operating characteristic (ROC) analysis, the model with the highest area under curve (AUC) was selected as the best performing model to establish the risk predictive nomogram and web calculator. Results: In distal metastasis risk prediction, the XGB model had the best performance in both training (AUC = 0.91) and testing (AUC = 0.851) datasets among the six ML algorithms. Variables including marital status, sequence number, primary site, grade, pathological type, T-stage, N-stage, the calculated risk of XGB, surgical and radiation treatment were incorporated to establish a nomogram to predict the 1-, 3-, and 5-years survival probability. The calibration plots, decision curve analysis (DCA), ROC curves and Kaplan-Meier (KM) curves all verified the predictive utility of the nomogram. Conclusions: We established a favorable prediction for the occurrence of distal metastasis with the ML model. The nomogram based on XGB algorithm can contribute to identify high-risk patients and provide optimal clinical strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.